PTGS2 and cancer: More disturbing is the observation that the anti-proliferative effects of COX-2 inhibitors on cancer cells have also been demonstrated in COX-2-deficient cells [18-21], suggesting that the role of COX-2 and its product PGE2 in cancer might have been overvalued based on the effects of pharmacological COX-2 inhibitors.